Grace Therapeutics GRCE
NASDAQ GRCE
$2.14 +0.04 (+1.66%)
As of: Sep 30, 2026 · 3:56 PM EDT

Grace Therapeutics (GRCE) Other Operating Expenses (2022 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Other Operating Expenses of $898,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9.1% from $988,000 a year earlier and down 42.0% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Operating Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Grace Therapeutics' Other Operating Expenses came in at $4.42 million as of Jun 30, 2026, up 38.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.51 million, up 21.7% from FY2025.

  • Annual Other Operating Expenses has a three-year compound annual growth rate of 666.9% (FY2023 to FY2026).
  • Across earlier fiscal years, Other Operating Expenses came in at $3.71 million in FY2025 (+6.7%), $3.48 million in FY2024 and $10,000 in FY2023.
  • Quarterly Other Operating Expenses has ranged from $4,000 in fiscal Q2 2023 to $1.55 million in fiscal Q4 2026 over the past five years.
  • On a year-over-year basis, Other Operating Expenses rose in three of the last five quarters, with growth averaging 32.6%.
  • Per Business Quant, the preceding three fiscal quarters came in at $1.55 million (Q4 2026), $870,000 (Q3 2026) and $1.1 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Grace Therapeutics 34.34 Mn 34.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 898,000.00
Mar 31, 2026 1.55 Mn
Dec 31, 2025 870,000.00
Sep 30, 2025 1.10 Mn
Jun 30, 2025 988,000.00
Mar 31, 2025 612,000.00
Dec 31, 2024 620,000.00
Sep 30, 2024 981,000.00
Jun 30, 2024 1.49 Mn
Sep 30, 2022 4,000.00
Jun 30, 2022 6,000.00
API Access

Grace Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY